Liver SBRT in Combination With Immune Checkpoint Inhibition in Patients With Metastatic Non-small Cell Lung Cancer
Clinical trial NCT05430009 · UNKNOWN
Trial details
- NCT number
- NCT05430009
- Sponsor
- VA Ann Arbor Healthcare System
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-06-17
- Primary completion
- 2025-12-15
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.